论文部分内容阅读
作者报道39名正常人及200例各型病毒性肝炎患者的血浆组织纤溶酶原激活剂(t-PA)和纤溶酶原激活剂抑制剂(PAI)的测定结果:正常人组t-PA和PAI分别为1.92±0.72IU/ml和6.38±2.57AU/ml;各型肝炎组的t-PA活性较正常人组高(P<0.001),PAI活性较正常人组低(P<0.001)两者均随病情的严重程度变化。
The authors reported the plasma levels of plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) in 39 normal subjects and 200 patients with various types of viral hepatitis: Results from t- PA and PAI were 1.92 ± 0.72IU / ml and 6.38 ± 2.57AU / ml, respectively. The t-PA activity in each hepatitis group was higher than that in normal people (P <0.001) Both vary with the severity of the condition.